Skip to main content

‘Avengers: Endgame’ Smashes Global Box Office Record With $1.2 Billion

The game has now moved to a whole new level, with the Avengers smashing opening-weekend records with a global $1.2 billion take at the box office, Walt Disney Co. said on Sunday.

"Avengers: Endgame" took in $350 million in the U.S. and Canada, blowing through the previous record of $258 million that was held by the superhero team's own gloved hands with last year's “Infinity War." Disney now boasts the top four spots for opening weekends in the U.S. and Canada, rounded out by "The Last Jedi" and "The Force Awakens" from the Star Wars franchise, according to researcher Comscore Inc.

The worldwide total included $330.5 million in China, and records fell like skyscrapers under attack. "Avengers: Endgame" took in a domestic record of $156.7 million on its first day, including Thursday night previews, beating the previous mark of $119 million held by "Star Wars: The Force Awakens" in 2015.

The picture, the latest installment from Disney's Marvel studio, caps a 22-movie storyline that began with "Iron Man" in 2008. The Avengers superheroes, including Captain America, Hulk and Black Widow, are now battling the intergalactic villain Thanos, who was last seen wiping out half the living creatures in the universe.

Disney, which also owns the Star Wars franchise and is usually cautious with forecasts, had originally suggested an opening weekend in the $300 million range.

What Bloomberg Intelligence Says

"The $60 million taken in from Thursday night previews is the highest ever, and suggests a domestic tally of more than $800 million, with a potential to break $2.5 billion globally. That could also help movie theaters get a boost, potentially offsetting the 17% slump year-to-date."

–Geetha Ranganathan, senior industry analyst Click here to view the piece

With this kind of juice, there's every reason to believe "Endgame" will challenge the $2.07 billion worldwide gross of "The Force Awakens," set in 2015. Only two other films in Hollywood history have taken in more: "Avatar" in 2009 and "Titanic," released in 1997.

The Marvel machine has been a huge moneymaker for Disney. Last year's "Infinity War," for example, earned an estimated $985 million in profit, including TV, toys and theater ticket sales.



from Fortune http://bit.ly/2UOKRBT

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be